drugset / Trial / NCT03639922
Imatinib in Acute Ischaemic Stroke
RandomizedParallel-groupTriple-blindTreatment
Summary
A clinical trial comparing treatment with Imatinib to placebo when administered within 8 hours of stroke onset for 6 days, in addition to conventional stroke treatment after acute ischaemic stroke.
Timeline
- Start
- 2018-10-01
- Primary completion
- 2022-12
- Completion
- 2023-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Imatinib | Small molecule | 400 mg | — |